Search alternatives:
significant complications » significant complication (Expand Search), significant implications (Expand Search), significant applications (Expand Search)
complications increases » combination increased (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
significant complications » significant complication (Expand Search), significant implications (Expand Search), significant applications (Expand Search)
complications increases » combination increased (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
-
1
-
2
-
3
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
Published 2025Subjects: -
4
-
5
Supplementary Material for: Enhanced Recovery after Surgery for Radical Cystectomy Decreases Postoperative Complications at Different Times
Published 2021“…<b><i>Results:</i></b> A total of 150 patients underwent radical cystectomy, 74 without ERAS and 76 with ERAS protocol. ERAS decreased significantly early (<i>p</i> = 0.039) and 90-day (0.012) postoperative complications. …”
-
6
-
7
-
8
Complications.
Published 2024“…The mean medication burden decreased significantly from 2.5 to 1.1 for iStent (55.0% reduction, <i>P</i><0.01) and 2.9 to 1.7 for iStent inject (46.8% reduction, <i>P</i><0.01), with no significant differences between the two groups (<i>P</i> = 0.17). …”
-
9
Mean and standard error of the mean for force capability according to anchor point level change.
Published 2022Subjects: -
10
-
11
-
12
-
13
Spatial information is significantly decreased in dCA1 and vCA1 in APP/PS1 mice.
Published 2024“…(B) In dCA1, spatial information was decreased in APP/PS1 mice relative to C57BL/6 controls (mean ± std: C57BL/6 = 0.132 ± 0.048, APP/PS1 = 0.128 ± 0.051, p < 0.005, two-sided Wilcoxon rank-sum test, n<sub>C57BL/6</sub> = 305 units from 5 recording sessions, n<sub>APP/PS1</sub> = 180 units from 4 recording sessions). …”
-
14
-
15
-
16
-
17
-
18
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
19
-
20
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: